stavudine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyash, M; Cohen, M; Ehrlich, A; Ioannidis, K; Nahmias, Y; Note, R; Ouedraogo, G; Riu, A; Tsytkin-Kirschenzweig, S; Vanfleteren, J | 1 |
| Bauerfeind, R; Behrens, GM; Binz, A; Leverkus, M; Panayotova-Dimitrova, D; Stankov, MV; Vondran, FW | 1 |
2 other study(ies) available for stavudine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Microphysiological flux balance platform unravels the dynamics of drug induced steatosis.
Topics: Cell Line; Hepatocytes; Humans; Lab-On-A-Chip Devices; Metabolic Flux Analysis; Non-alcoholic Fatty Liver Disease; Stavudine; Valproic Acid | 2018 |
Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.
Topics: Anti-HIV Agents; Autophagy; Blotting, Western; Cells, Cultured; DNA, Mitochondrial; Fatty Liver; Female; Flow Cytometry; Hep G2 Cells; HIV Infections; Humans; Lipid Metabolism; Male; Microscopy, Electron; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Stavudine; Thymidine; Zidovudine | 2012 |